February 2024
The saliva collection and diagnostics market revenue is expected to attain around USD 1,245.46 million by 2033 from USD 819.67 million in 2024, with a CAGR of 4.76% during the forecast period. The demand for the saliva collection and diagnostics market is increasing due to the rising need for quick diagnoses of diseases.
The saliva collection and diagnostics market collects, analyzes, and interprets saliva samples for healthcare and research purposes. It also includes the use of saliva for diagnosing diseases, biomedical research, and non-invasive drug testing. Saliva is an essential source of bodily information as it contains biomarkers like DNA and other proteins that can help to identify the presence of certain diseases, such as cancers and cardiovascular disease.
Rising introduction of new technologies
In the saliva collection and diagnostics market, new technologies like point-of-care (POC) testing are making precise saliva testing, providing cost-effectiveness. POC testing enables rapid analysis of on-site saliva samples, which are necessary in primary care clinics, emergency departments, and remote areas. However, there is an increasing demand for saliva-based assays that can detect biomarkers related to certain disease conditions.
Increasing interest in personalized medicine
Innovations in proteomic and genomic technologies have grown the presence of saliva biomarkers that can be processed. This also allows the development of targeted diagnostic tests for an extensive range of health ailments. Furthermore, saliva samples are easy to collect from different surfaces. This makes it a preferred choice for forensic investigations and crime scenes.
Growing cases of hormonal imbalance among women
The saliva-based test is accurate and painless. These tests are convenient ways to analyze hormone levels in women. In the past years, blood tests have been the only way to measure these hormone levels in women. But it is quite expensive nowadays. In addition, saliva-based diagnoses are utilized to measure a number of physiological conditions like depression, stress, and sleep disturbances.
North America dominated the saliva collection and diagnostics market in 2023. The region's dominance can be credited to the growing preference for saliva-based tests and the surge in cases of infectious diseases globally. Furthermore, the U.S. led the market due to increasing demand for non-invasive testing methods provided by saliva sampling. Also, the strong presence of medical infrastructure is supporting market expansion further in the region.
Asia Pacific is anticipated to grow at the fastest rate in the saliva collection and diagnostics market during the forecast period. The growth of the region can be linked to the increasing prevalence of infectious diseases in crowded countries like India and China where these tests are important. Moreover, saliva testing has gained prominence because of its non-invasive nature and ease of collection.
Report Attribute | Key Statistics |
Market Revenue in 2024 | USD 819.67 Million |
Market Revenue by 2033 | USD 1,245.46 Million |
CAGR | 4.76% from 2024 to 2033 |
Quantitative Units | Revenue in USD million/billion, Volume in units |
Largest Market | North America |
Base Year | 2023 |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Segmentation
By Site of Collection
By Application
By End-Use
Get this report to explore global market size, share, CAGR and trends, featuring detailed segmental analysis and an insightful competitive landscape overview@ https://www.precedenceresearch.com/checkout/5276
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344
February 2024
October 2023
July 2023
July 2022